Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Longitudinal patient-reported outcomes in patients receiving chimeric antigen receptor T-cell therapy

30 Mar 2023

Abstract excerpt

Chimeric antigen receptor T-cell therapy (CAR-T) has transformed the treatment for relapsed/refractory hematologic malignancies; however, data on patient-reported outcomes in CAR-T are limited. We conducted a longitudinal study of adults with hematologic malignancies receiving CAR-T. We assessed quality of life (QOL; functional assessment of cancer therapy-general), psychological distress (hospital anxiety and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Ethics and Regulation
Share to CAR-T cell therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36995091
DOI: 10.1182/bloodadvances.2022009117

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Longitudinal patient-reported outcomes in patients receiving chimeric antigen receptor T-cell therapyPMID 36995091Read ↗

Quality of Life and Prognostic Awareness in Caregivers of Patients Receiving Chimeric Antigen Receptor T Cell TherapySemantic proximity Read ↗

The heightened impact of COVID-19 on emotional wellbeing and delays in care in patients with cutaneous T-cell lymphoma: A cross-sectional studySemantic proximity Read ↗

Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Patients with LymphomaSemantic proximity Read ↗

The symptom phenotype of oncology outpatients remains relatively stable from prior to through 1 week following chemotherapy.Semantic proximity Read ↗

Cytokine gene variation is associated with depressive symptom trajectories in oncology patients and family caregivers.Semantic proximity Read ↗

Beyond Disease Control in Chronic Myeloid Leukemia: Real-World Quality of Life Across TKIs and Treatment-Free RemissionSemantic proximity Read ↗

The Impact of Depression on Survival and Treatment Adherence in Cancer Patients: A Systematic ReviewSemantic proximity Read ↗

Symptom Distress, Resourcefulness, and Quality of Life in Patients Receiving Chemotherapy: The Moderating Role of Cancer MetastasisSemantic proximity Read ↗

Long-term health-related quality of life and mental health in patients with immune thrombotic thrombocytopenic purpuraSemantic proximity Read ↗

Function, Adjustment, Quality of Life and Symptoms (FAQS) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Survivors: A Study ProtocolSemantic proximity Read ↗

Late Effects of Cancer and Hematopoietic Stem-Cell Transplantation on Spouses or Partners Compared With Survivors and Survivor-Matched ControlsSemantic proximity Read ↗

The EORTC QLQ-HDC29: A supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.